PEDIATRICS Vol. 107 No. 2 February 2001, pp. 416-417
EXPERIENCE AND REASON:
A Case of Protein-Losing Enteropathy Caused by Intestinal
Lymphangiectasia in a Preterm Infant
| |
ABSTRACT |
|---|
|
|
|---|
Intestinal lymphangiectasia is characterized by
obstruction of lymph drainage from the small intestine and lacteal
dilation that distorts the villus architecture. Lymphatic vessel
obstruction and elevated intestinal lymphatic pressure in turn cause
lymphatic leakage into the intestinal lumen, thus resulting in
malabsorption and protein-losing enteropathy. Intestinal
lymphangiectasia can be congenital or secondary to a disease that
blocks intestinal lymph drainage. We describe the first case of
intestinal lymphangiectasia in a premature infant. The infant
presented with peripheral edema and low serum albumin; high fecal
concentration of
1-antitrypsin documented intestinal
protein loss. Endoscopy showed white opaque spots on the duodenal
mucosa, which indicates dilated lacteal vessels. Histology confirmed
dilated lacteals and also showed villus blunting. A formula containing
a high concentration of medium chain triglycerides resulted in a rapid
clinical improvement and normalization of biochemical variables. These
features should alert neonatologists to the possibility of intestinal
lymphangiectasia in newborns with hypoalbuminemia and peripheral edema.
The intestinal tract should be examined for enteric protein losses if
other causes (ie, malnutrition and protein loss from other sites) are
excluded. The diagnosis rests on jejunal biopsy demonstrating dilated
lymphatic lacteal vessels.
Protein-losing gastroenteropathy (PLGE) includes a large
group of diseases characterized by enteric loss of plasma proteins in
abnormal amounts.1 In most instances, PLGE is caused by
enhanced mucosal permeability to proteins consequent to cell damage,
mucosal erosions or ulcerations, and lymphatic obstruction.
Protein-losing gastroenteropathy includes nonulcerative diseases
(eosinophil gastroenteritis and Menetrier's disease); ulcerative
diseases (erosive gastritis and inflamed bowel disease); and disorders
resulting from lymphatic obstruction (congenital intestinal
lymphangiectasia and Whipple's disease).
Intestinal lymphangiectasia is characterized by obstruction of lymph
drainage from the small intestine and dilated lacteal vessels that
distort the villus architecture. It is often observed in adults and
older children; it has been described prenatally and in 2 full-term
siblings.2,3 There are no previous reports of this entity
in premature infants.
This infant boy, born at 30 weeks gestation and weighing
1210 g, had hyaline membrane disease and grade II intraventricular cerebral hemorrhage during the first days of life. He was admitted to
the neonatal intensive care unit and given expressed breast milk and a
formula for preterm infants (Similac Special Care Formula, Ross
Laboratories, Columbus, OH). He developed edema on the legs and head
during the first week of life. Concentrations of serum albumin (2.0 g/dL), immunoglobulin G (IgG) (324 mg/dL), and transferrin were
low. Serum immunoglobulin A (IgA) (6.2 mg/dL) and immunoglobulin M
(IgM) concentrations were normal. Blood cell count excluded lymphocytopenia. Proteinuria, inadequate protein intake, and liver and
heart diseases were excluded. High
![]()
CASE REPORT
1-antitrypsin stool levels (>3 mg/g
dry-weight sample) and fecal
1-antitrypsin
clearance (65 mL/die) indicated enteric loss of plasma proteins. Upper
intestinal endoscopy, performed with a neonatal fiberscope (5.5 mm
diameter; Olympus, Turin, Italy), without sedation showed white opaque
spots on the duodenum mucosa, and 2 biopsies were taken from the areas most affected. Duodenal histology showed a distorted villus profile attributable to dilated lymphatic channels and areas of villus blunting
intermingled with seemingly normal areas (Fig
1). The esophageal and gastric mucosa
appeared histologically normal. Ultrasound examination of the heart and
abdomen excluded secondary causes of lymphangiectasia (ie, chronic
congestive heart failure, constrictive pericarditis, pericardial
effusion, abdominal masses, and intestinal malrotation). The final
diagnosis was congenital intestinal lymphangiectasia.

View larger version (136K):
[in a new window]
Fig. 1.
Histologic image of the duodenal mucosa showing the villus architecture
distorted by dilatation of the lymphatic vessels. Note the normal
villus on the left.
Breast milk and adapted formula were replaced by a formula with a high
concentration of medium chain triglycerides (Portagen, Mead
Johnson Nutritionals, Rome, Italy), which caused a rapid clinical improvement. At follow-up, the serum albumin level had increased remarkably (3.1-3.8 g/dL) and
1-antitrypsin stool levels were normal; edema
had regressed and the infant had gained weight. When the infant
was 6 months old, beikost and medium chain triglycerides were
introduced as the sole sources of fat in his diet. At present, the
infant is 1 year old and is growing well.
| |
DISCUSSION |
|---|
|
|
|---|
Intestinal lymphangiectasia is characterized by obstruction of the intestinal lymphatic vessels and increased lymphatic pressure that cause PLGE and malabsorption of chylomicrons and fat-soluble vitamins. Intestinal lymphangiectasia is a primary disorder in cases of malformation of lymphatic vessels at intestinal level or in other areas of the body. It can also occur secondary to diseases that cause intestinal lymphatic obstruction, eg, abdominal or retroperitoneal tumors, retroperitoneal fibrosis, chronic pancreatitis, mesenteric tuberculosis, Crohn's disease, intestinal malrotation, Whipple's disease, celiac disease constrictive pericarditis, and chronic congestive heart failure.1,4,5
We describe the first case of intestinal lymphangiectasia in a preterm
infant. This entity is rarely suspected in the differential diagnosis
of a tiny newborn with peripheral edema and hypoalbuminemia. These
features should alert pediatricians to the possibility of enteric loss
of proteins if other causes, such as malnutrition and hepatic and renal
diseases, are excluded. In our case, an excessive concentration of
1-antitrypsin measured in random dry stool and
the high plasma clearance of
1-antitrypsin
demonstrated an abnormal enteric loss of proteins. In earlier studies,
both tests have detected abnormal enteric loss of
proteins.6,7 Differently, radioactive methods, including
intravenous administration of 51Cr albumin or
51Cr chloride, are cumbersome and expensive, and
are rarely used because radioactive macromolecules are not widely
available.
Although lymphocytopenia is supposedly a marker of intestinal lymphatic channel obstruction, it was not found in our patient. This coincides with reports that lymphopenia was not present during the early phases of intestinal lymphangiectasia in young children.2,3 Furthermore, drainage of lymphocytes through the lamina propria can be unremarkable in the absence of inflammatory activation in the intestinal mucosa.3
Endoscopy of the upper intestinal tract was crucial in establishing the diagnosis of intestinal lymphangiectasia. In fact, white opaque spots detected on the duodenal mucosa and biopsies sampled during endoscopy showed dilated lymphatic channels. Because the mucosal lesions in intestinal lymphangiectasia are often patchy and localized, endoscopy is an aid to selecting regions for biopsy. Differently, multiple mucosal biopsies may be necessary if peroral jejunal sampling is used.8 In our case, ultrasound excluded other causes of lymphatic obstruction and excessive protein efflux into the intestinal tract, eg, constrictive pericarditis, pericardial effusion, superior vena cava obstruction, heart failure, intestinal malrotation, and intestinal tumors.
| |
CONCLUSION |
|---|
|
|
|---|
In summary, although intestinal lymphangiectasia primarily affects children and young adults, it should be included in the diagnostic work-up in preterm infants presenting with peripheral edema and hypoproteinemia when there is excessive enteric protein loss. An early diagnosis of intestinal lymphangiectasia in newborns and small infants may prevent such severe complications as lymphocytopenia and malnutrition. Endoscopy can be successfully performed even in preterm neonates to explore the upper gastrointestinal mucosa.
| |
ACKNOWLEDGMENT |
|---|
We thank Jean Ann Gilder for editing the text.
Gastrointestinal Endoscopy and Motility Unit
* Neonatal Intensive Care Unit
Department of Pediatrics
University of Naples, "Federico II'
Via Sergio Pansini 5, I-80131, Naples, Italy
| |
FOOTNOTES |
|---|
Received for publication Feb 25, 2000; accepted May 9, 2000.
Address correspondence to Salvatore Cucchiara, MD, Department of Pediatrics, Gastrointestinal Motility and Endoscopy Unit, University of Naples "Federico II,' Via Sergio Pansini 5, I-80131 Naples, Italy. E-mail: cucchiar{at}unina.it
| |
ABBREVIATIONS |
|---|
PLGE, protein-losing gastroenteropathy, Ig, immunoglobulin.
| |
REFERENCES |
|---|
|
|
|---|
- Levin Marc S. Protein losing gastroenteropathy. In: Yamada T, Alpers DH, Laine L, Owyang C, Powell DW, eds. Textbook of Gastroenterology. 3rd ed. Baltimore, MD: Lippincott Williams & Wilkins; 1999:1752-1753
- Munick A, Foucaud P, Walti H, Dumez Y, Vaudour G, Navarro J Intestinal lymphangiectasia revealed in prenatal age. Arch Fr Pediatr. 1986; 43:195-196 [Medline]
- Hardikar W, Smith A, and Chow CW Neonatal protein-losing enteropathy caused by intestinal lymphatic hypoplasia in siblings. J Pediatr Gastroenterol Nutr. 1997; 25:217-221 [CrossRef][Medline]
- van Tilburg AJ, van Blankenstein M, Verschoor L Intestinal lymphangiectasia in systemic sclerosis. Am J Gastroenterol. 1988; 83:1418-1419 [Medline]
-
Perisic VN,
Kokai G
Coeliac disease and lymphangiectasia.
Arch
Dis Child.
1992;
67:134-136
[Abstract/Free Full Text] - Thomas DW Random fecal alpha-1-antitrypsin concentration in children with gastrointestinal disease. Gastroenterology. 1981; 80:776-782 [Medline]
- Florent C, L'Hirondel C, Desmazures C, Aymes C, Bernier JJ Intestinal clearance of alpha 1-antitrypsin. A sensitive method for the detection of protein-losing enteropathy. Gastroenterology. 1981; 81:777-780 [Medline]
- Salomons HA, Kramer P, Nikulasson S, Schroy PC Endoscopic features of long-standing primary intestinal lymphangiectasia. Gastrointest Endosc. 1995; 41:516-518 [CrossRef][Medline]
Pediatrics (ISSN 0031 4005). Copyright ©2001 by the American Academy of Pediatrics
This article has been cited by other articles:
![]() |
R. Chera, A. A. Gupta, D. Bailey, G. R. Somers, V. Kukreti, and M. Crump Small Intestinal B-Cell Lymphoma in a Patient With Lymphangiectasia Secondary to Abdominal Lymphangioma J. Clin. Oncol., February 1, 2008; 26(4): 675 - 678. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||





